Niagen Bioscience launches drug candidate for rare genetic disease
Go back to Niagen Bioscience launches drug candidate for rare genetic disease| (NASDAQ: NAGE) | Delayed: 2.99 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.99 | 52 Week High | $ | |||
| Open | $2.99 | 52 Week Low | $ | |||
| Day High | $3.03 | P/E | N/A | |||
| Day Low | $2.97 | EPS | $ | |||
| Volume | 609,158 | |||||

